Rituximab (Mabthera) is a monoclol antibody, prescribed for certain types of cancer such as lymphomas, leukemia, transplant rejection and some autoimmune disorders.It decreases the number of certain types of white blood cells (B cells) in the body.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
Mabthera - Roche Pharmaceuticals
Mabthera Infusion
Generic : Rituximab
₹
17712
100mg/10ml
1vial
Substitute/Alternative Medication to Mabthera
When is Mabthera prescribed?
It is prescribed for -